Table 2.

Hemophilia gene and cell therapy programs in late preclinical, IND-enabling, and/or clinical investigations

Hemophilia gene and cell therapy programs in late preclinical, IND-enabling, and/or clinical investigations
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal